Clinical Trial Update: A Phase II Study of Dacomitinib in Progressive Brain Metastases [Phase 2]

View source ↗

Summary

This clinical trial update notes the termination of a Phase II study of dacomitinib in progressive brain metastases, with results posted in August 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Dacomitinib (dacomitinib)

Snippet

Sponsor: David Piccioni, M.D., Ph.D | Conditions: Brain Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-08-09